Literature DB >> 8460714

Phospholipase A2 in alveolar type II epithelial cells: biochemical and immunologic characterization.

G R Neagos1, A Feyssa, M Peters-Golden.   

Abstract

The enzyme phospholipase A2 (PLA2) catalyzes phospholipid hydrolysis and is thought to play important roles in surfactant synthesis and in the generation of lipid mediators, including eicosanoids and platelet-activating factor. This study sought to characterize PLA2 in rat type II pneumocytes by biochemical and immunologic means. Type II cells were found to contain an alkaline-active, Ca(2+)-dependent PLA2 activity predominantly localized to cytosol fraction. This activity preferred phospholipids containing arachidonate in the sn-2 position and phosphatidylethanolamine (PE) over phosphatidylcholine (PC); it was active at physiologically relevant Ca2+ concentrations and was resistant to dithiothreitol. These biochemical features were suggestive of a high-molecular-weight form of PLA2, and immunoblot analysis of type II cell extracts indeed detected a 97-kDa protein corresponding to a high-molecular-weight PLA2, but no low-molecular-weight pancreatic-type enzyme. Human A549 cells, which share certain features with type II cells, contained a similar PLA2 activity and immunoreactive protein. By contrast, whole rat lung cytosol contained both a 97-kDa PLA2 and a 14-kDa pancreatic-type PLA2, but its activity was typical of the latter in that it lacked sn-2 specificity for arachidonate and was inhibited by dithiothreitol. These results indicate that rat type II as well as human A549 epithelial cells contain a high-molecular-weight PLA2, for which mounting evidence suggests an important role in physiological and pathophysiological situations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8460714     DOI: 10.1152/ajplung.1993.264.3.L261

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Playing "telephone": bioactive lipids as mediators of intercompartmental communication in the alveolus.

Authors:  M Peters-Golden
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  The MAP kinase inhibitors, PD098059, UO126 and SB203580, inhibit IL-1beta-dependent PGE(2) release via mechanistically distinct processes.

Authors:  R Newton; L Cambridge; L A Hart; D A Stevens; M A Lindsay; P J Barnes
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

3.  Purification and characterization of a calcium-independent acidic phospholipase A2 from rat lung.

Authors:  R Wang; C R Dodia; M K Jain; A B Fisher
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

4.  Translocation of cytosolic phospholipase A2 to the nuclear envelope elicits topographically localized phospholipid hydrolysis.

Authors:  M Peters-Golden; K Song; T Marshall; T Brock
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

5.  Dipalmitoyl-phosphatidylcholine biosynthesis is induced by non-injurious mechanical stretch in a model of alveolar type II cells.

Authors:  Despoina Pantazi; Eirini Kitsiouli; Athanasios Karkabounas; Theoni Trangas; George Nakos; Marilena E Lekka
Journal:  Lipids       Date:  2013-06-02       Impact factor: 1.880

6.  A novel signaling mechanism between gas and blood compartments of the lung.

Authors:  W M Kuebler; K Parthasarathi; P M Wang; J Bhattacharya
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

7.  Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool.

Authors:  M Triggiani; A Oriente; M C Seeds; D A Bass; G Marone; F H Chilton
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.